Jaka Strel, Metka Križič, Biljana Nikolova Stoilova, Ivan Pecev, Rebeka Novak, Matija Kiker, Tinkara Royal Mlinar
{"title":"Clinical validation of MESI mTABLET BP according to ISO 81060-2:2018 + A1 + A2.","authors":"Jaka Strel, Metka Križič, Biljana Nikolova Stoilova, Ivan Pecev, Rebeka Novak, Matija Kiker, Tinkara Royal Mlinar","doi":"10.1097/MBP.0000000000000825","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to clinically validate the MESI mTABLET BP device in accordance with the protocol outlined in ISO 81060-2:2018 + A1 + A2.</p><p><strong>Methods: </strong>A total of 127 adult participants were enrolled, of whom 36 were excluded. The final study sample consisted of 91 participants with upper arm circumferences ranging from 22 to 50 cm. Blood pressure measurements obtained with the MESI mTABLET BP were compared with reference auscultatory measurements performed simultaneously by two trained observers. A same-arm sequential method was used, in which each MESI mTABLET BP measurement was compared against the average of the preceding and subsequent reference measurements. The study was approved by the National Medical Ethics Committee of the Republic of Slovenia.</p><p><strong>Results: </strong>The mean blood pressure difference between MESI mTABLET BP and the reference auscultatory method was 1.6 ± 4.3 mmHg for SBP and 1.9 ± 5.1 mmHg for DBP; hence, criterion 1 from the standard was fulfilled (required |mean| ≤5.00, SD ≤8.00 mmHg). Criterion 2 was also met, as the SD of average paired determinations per participant was ±3.56 mmHg for SBP and ±4.66 mmHg for DBP (required ≤6.76 and ≤6.68 mmHg, respectively).</p><p><strong>Conclusion: </strong>The MESI mTABLET BP demonstrated clinical accuracy and reliability, and can hence be recommended for use in clinical and primary care settings in adult populations with upper arm circumferences between 22 and 50 cm, as validated in the present study.</p>","PeriodicalId":8950,"journal":{"name":"Blood Pressure Monitoring","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Pressure Monitoring","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MBP.0000000000000825","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The objective of this study was to clinically validate the MESI mTABLET BP device in accordance with the protocol outlined in ISO 81060-2:2018 + A1 + A2.
Methods: A total of 127 adult participants were enrolled, of whom 36 were excluded. The final study sample consisted of 91 participants with upper arm circumferences ranging from 22 to 50 cm. Blood pressure measurements obtained with the MESI mTABLET BP were compared with reference auscultatory measurements performed simultaneously by two trained observers. A same-arm sequential method was used, in which each MESI mTABLET BP measurement was compared against the average of the preceding and subsequent reference measurements. The study was approved by the National Medical Ethics Committee of the Republic of Slovenia.
Results: The mean blood pressure difference between MESI mTABLET BP and the reference auscultatory method was 1.6 ± 4.3 mmHg for SBP and 1.9 ± 5.1 mmHg for DBP; hence, criterion 1 from the standard was fulfilled (required |mean| ≤5.00, SD ≤8.00 mmHg). Criterion 2 was also met, as the SD of average paired determinations per participant was ±3.56 mmHg for SBP and ±4.66 mmHg for DBP (required ≤6.76 and ≤6.68 mmHg, respectively).
Conclusion: The MESI mTABLET BP demonstrated clinical accuracy and reliability, and can hence be recommended for use in clinical and primary care settings in adult populations with upper arm circumferences between 22 and 50 cm, as validated in the present study.
期刊介绍:
Blood Pressure Monitoring is devoted to original research in blood pressure measurement and blood pressure variability. It includes device technology, analytical methodology of blood pressure over time and its variability, clinical trials - including, but not limited to, pharmacology - involving blood pressure monitoring, blood pressure reactivity, patient evaluation, and outcomes and effectiveness research.
This innovative journal contains papers dealing with all aspects of manual, automated, and ambulatory monitoring. Basic and clinical science papers are considered although the emphasis is on clinical medicine.
Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.